Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Tran

Physical Medicine & Rehabilitation Alpharetta, GA Medical Doctor

NPI 1023300266 CMS profile 1356850

4165 Old Milton Pkwy Ste 170, Alpharetta, GA 30005

Open in the dashboard

General payments

$96,075

296 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, David Tran of Alpharetta, GA is reported in the CMS Open Payments database as having received $96,075 across 296 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physical Medicine & Rehabilitation profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $40,153 112
2024 General $42,921 97
2023 General $9,828 38
2022 General $747 9
2021 General $271 6
2020 General $1,456 20
2019 General $699 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Tran
  • Physical Medicine & Rehabilitation median
  • Middle half of Physical Medicine & Rehabilitation
  • National median

In program year 2025, general payments to David Tran were reported at $40,153. Among 4,146 Physical Medicine & Rehabilitation profiles paid that year, the median was $139 and the middle half received between $48 and $410.

Show as a table
Year David Tran Physical Medicine & Rehabilitation median Middle half National median
2019 $699 $133 $45–$390 $163
2020 $1,456 $88 $29–$272 $114
2021 $271 $116 $33–$360 $132
2022 $747 $123 $40–$378 $149
2023 $9,828 $131 $43–$396 $160
2024 $42,921 $141 $45–$409 $164
2025 $40,153 $139 $48–$410 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $82,895 204 payments
  2. Relievant Medsystems, Inc. $11,173 49 payments
  3. Nevro Corp. $679 15 payments
  4. Electronic Waveform Lab, Inc. $477 2 payments
  5. Stryker Corporation $156 1 payment
  6. AbbVie, Inc. $111 1 payment
  7. Abbott Laboratories $92 4 payments
  8. Otsuka Pharmaceutical Development & Commercialization, Inc. $72 1 payment
  9. Medtronic, Inc. $58 3 payments
  10. Baxter Healthcare $56 2 payments
  11. Other $306 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $69,513 137 payments
  2. Travel and Lodging $13,265 38 payments
  3. Consulting Fee $7,200 2 payments
  4. Food and Beverage $6,096 119 payments
Products named General payments · program years 2019–2025
  1. Intracept Contains (1)Intracept RF Probe (2)Intracept Access Instruments_NMOD $37,912 94 payments
  2. Intracept Pain $16,042 47 payments
  3. Intracept Pain $9,647 30 payments
  4. Intracept Pain $9,647 30 payments
  5. Intracept Pain $9,647 30 payments
  6. General - Therapies $1,692 5 payments
  7. Intracept Pain $1,280 13 payments
  8. Senza Spinal Cord Stimulation System $466 11 payments
  9. Intracept Pain $246 6 payments
  10. Omnia $178 2 payments
  11. Other $1,228 36 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

17

Median for Physical Medicine and Rehabilitation: 276

Drug cost

$148

Median for Physical Medicine and Rehabilitation: $5,921

Branded share of claims

0%

Median for Physical Medicine and Rehabilitation: 11.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 17 $148

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 39 billing codes

Paid by Medicare

$33,497

Medicare's payments for the services billed

Medicare patients

58

Average age 73

Services billed

325

37 women, 21 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Ischemic heart disease 40%
Osteoporosis 28%
Depression 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

296 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physical Medicine & Rehabilitation in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record